https://www.selleckchem.com/pr....oducts/marimastat.ht
049% (40-49 years), 0.052%(50-59 years), 0.071% (60-69 years), 0.133% (70-79 years), and 0.352% (80-89 years). The percentage of deaths per ASA score was 0% (ASA I), 0.035% (ASA II), 0.174% (ASA III), and 1.008% (ASA IV). The percentage of deaths per CCI score was 0.09% (CCI= , 0.23% (CCI= 1), 0.74% (CCI= 2), 3.21% (CCI= 3), 4.76% (CCI= 4), and 0.57% (CCI ≥ 5). Non-OA diagnoses were significantly more frequent in the mortality cohort (16.0% vs 7.6%; P .001). The risk of mortality was highest in patients aged 80-89, patients of
Like
Comment
Share
